FAB117-HC

· Ferrer Internacional S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FAB117-HC, covering 2021-09-16 to 2021-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury [Phase 1, Phase 2]

See pricing